Data gathered: December 21
Alternative Data for Aditxt
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 57 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 12,581 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Aditxt
None
| Price | $0.19 |
| Target Price | Sign up |
| Volume | 10,700,000 |
| Market Cap | $3.2M |
| Year Range | $0.19 - $120.4 |
| Dividend Yield | 0% |
| PE Ratio | 0 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Aditxt, Inc. (NASDAQ:ADTX) Short Interest UpdateDecember 13 - ETF Daily News |
|
Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Increases By 14.2%December 2 - ETF Daily News |
 |
ADTX stock plunges to 52-week low of $0.32 amid market challengesNovember 18 - Investing.com |
 |
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of SharesNovember 7 - Yahoo |
|
**Aditxt Discloses Information About Compliance with Nasdaq Listing Requirements in 8-K Filing** **November 6 - ETF Daily News |
|
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary AdifemNovember 5 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 6,900 | 470,000 | -460,000 | -13M | -4.7M | 0.000 |
| Q2 '24 | 44,000 | 23,000 | 21,000 | -7.5M | -6M | -4.189 |
| Q1 '24 | 80,000 | 66,000 | 14,000 | -15M | -12M | -36.820 |
| Q4 '23 | 81,000 | 290,000 | -200,000 | -11M | -8.2M | -1472.800 |
| Q3 '23 | 120,000 | 110,000 | 18,000 | -9.9M | -8.1M | -48.000 |
Insider Transactions View All
| HRT FINANCIAL LP filed to buy 25,434 shares at $1.5. October 17 '24 |
| BNP PARIBAS SECURITIES CORP filed to sell 22,342 shares at $33.2. September 7 '23 |
| Albanna Amro A. filed to buy 1 shares at $20000. July 21 '22 |
Similar companies
Read more about Aditxt (ADTX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Aditxt ?
The Market Cap of Aditxt is $3.2M.
What is Aditxt 's PE Ratio?
As of today, Aditxt 's PE (Price to Earnings) ratio is 0.
What is the current stock price of Aditxt ?
Currently, the price of one share of Aditxt stock is $0.19.
How can I analyze the ADTX stock price chart for investment decisions?
The ADTX stock price chart above provides a comprehensive visual representation of Aditxt 's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aditxt shares. Our platform offers an up-to-date ADTX stock price chart, along with technical data analysis and alternative data insights.
Does ADTX offer dividends to its shareholders?
As of our latest update, Aditxt (ADTX) does not offer dividends to its shareholders. Investors interested in Aditxt should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Aditxt ?
Some of the similar stocks of Aditxt are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.